Menu
GeneBe

SMARCAL1

SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1

Basic information

Region (hg38): 2:216412382-216483053

Links

ENSG00000138375NCBI:50485OMIM:606622HGNC:11102Uniprot:Q9NZC9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Schimke immuno-osseous dysplasia (Definitive), mode of inheritance: AR
  • Schimke immuno-osseous dysplasia (Strong), mode of inheritance: AR
  • Schimke immuno-osseous dysplasia (Supportive), mode of inheritance: AR
  • Schimke immuno-osseous dysplasia (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Schimke immunoosseous dysplasiaARAllergy/Immunology/InfectiousMany individuals have an associated risk for opportunistic infection due to T-cell deficiency, and prophylaxis (eg, against P. carinii) and early and aggressive treatment of infections can be beneficial; BMT has been describedAllergy/Immunology/Infectious; Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Renal4282260; 2397176; 2066860; 8267014; 9674900; 9632175; 10528861; 10653321; 11113849; 0710226; 11799392; 12471207; 15523612; 16419127; 17089404; 17676601; 20301550

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SMARCAL1 gene.

  • Schimke immuno-osseous dysplasia (865 variants)
  • not provided (125 variants)
  • Inborn genetic diseases (26 variants)
  • not specified (21 variants)
  • Focal segmental glomerulosclerosis (9 variants)
  • Kidney disorder (7 variants)
  • SMARCAL1-related condition (5 variants)
  • Nephrotic syndrome (3 variants)
  • Inherited Immunodeficiency Diseases (3 variants)
  • 9 conditions (2 variants)
  • Atypical hemolytic-uremic syndrome (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SMARCAL1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
329
clinvar
2
clinvar
334
missense
4
clinvar
9
clinvar
246
clinvar
10
clinvar
4
clinvar
273
nonsense
30
clinvar
2
clinvar
2
clinvar
34
start loss
0
frameshift
40
clinvar
2
clinvar
1
clinvar
43
inframe indel
3
clinvar
3
splice donor/acceptor (+/-2bp)
2
clinvar
13
clinvar
2
clinvar
17
splice region
2
7
35
1
45
non coding
9
clinvar
99
clinvar
41
clinvar
149
Total 76 26 266 438 47

Highest pathogenic variant AF is 0.000125

Variants in SMARCAL1

This is a list of pathogenic ClinVar variants found in the SMARCAL1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-216412428-T-C Schimke immuno-osseous dysplasia Uncertain significance (Feb 16, 2018)898338
2-216412444-G-C Schimke immuno-osseous dysplasia Uncertain significance (Jan 12, 2018)895358
2-216412482-C-G Schimke immuno-osseous dysplasia Uncertain significance (Jan 12, 2018)895359
2-216412526-C-T Schimke immuno-osseous dysplasia Benign (Jan 12, 2018)334280
2-216412544-G-A Schimke immuno-osseous dysplasia Likely benign (Apr 27, 2017)334281
2-216412574-C-T Schimke immuno-osseous dysplasia Uncertain significance (Jan 12, 2018)334282
2-216412580-G-A Schimke immuno-osseous dysplasia Uncertain significance (Jan 13, 2018)334283
2-216412603-G-A Schimke immuno-osseous dysplasia Uncertain significance (Jan 13, 2018)334284
2-216412607-A-G Schimke immuno-osseous dysplasia Likely benign (Apr 27, 2017)334285
2-216412630-G-A Schimke immuno-osseous dysplasia Uncertain significance (Jan 12, 2018)334286
2-216412803-G-A Uncertain significance (Jul 02, 2021)1678506
2-216413869-T-C Schimke immuno-osseous dysplasia Uncertain significance (Jan 12, 2018)334287
2-216414393-G-A Benign (Nov 12, 2018)1287616
2-216414437-G-A Benign (May 04, 2020)1259167
2-216414657-C-A Schimke immuno-osseous dysplasia Uncertain significance (Jan 13, 2018)334288
2-216414705-A-G SMARCAL1-related disorder Uncertain significance (Nov 04, 2023)3032866
2-216414709-C-T Schimke immuno-osseous dysplasia Uncertain significance (Aug 28, 2021)1448824
2-216414713-G-A Schimke immuno-osseous dysplasia Likely benign (Jul 31, 2023)1652074
2-216414729-C-G Schimke immuno-osseous dysplasia Uncertain significance (Mar 04, 2022)1980768
2-216414733-G-T Schimke immuno-osseous dysplasia Uncertain significance (Jun 23, 2022)2009523
2-216414737-A-G Schimke immuno-osseous dysplasia Likely benign (Jan 05, 2022)2075843
2-216414745-A-T Schimke immuno-osseous dysplasia • Inborn genetic diseases Uncertain significance (Dec 02, 2022)1519647
2-216414753-C-T Schimke immuno-osseous dysplasia Pathogenic (Sep 08, 2023)4172
2-216414754-G-A Schimke immuno-osseous dysplasia Uncertain significance (Jul 12, 2022)1896702
2-216414761-G-A Schimke immuno-osseous dysplasia Likely benign (Jan 02, 2022)2056165

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SMARCAL1protein_codingprotein_codingENST00000357276 1670640
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000002261.001256550931257480.000370
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8454545080.8940.00003056228
Missense in Polyphen165197.890.833782307
Synonymous-0.4522132051.040.00001301915
Loss of Function3.551741.70.4070.00000206501

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004600.000460
Ashkenazi Jewish0.002590.00258
East Asian0.00005440.0000544
Finnish0.0002770.000277
European (Non-Finnish)0.0004150.000413
Middle Eastern0.00005440.0000544
South Asian0.0001310.000131
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: ATP-dependent annealing helicase that binds selectively to fork DNA relative to ssDNA or dsDNA and catalyzes the rewinding of the stably unwound DNA. Rewinds single-stranded DNA bubbles that are stably bound by replication protein A (RPA). Acts throughout the genome to reanneal stably unwound DNA, performing the opposite reaction of many enzymes, such as helicases and polymerases, that unwind DNA. May play an important role in DNA damage response by acting at stalled replication forks. {ECO:0000269|PubMed:18974355, ECO:0000269|PubMed:19793861, ECO:0000269|PubMed:19793862}.;
Disease
DISEASE: Schimke immuno-osseous dysplasia (SIOD) [MIM:242900]: An autosomal recessive pleiotropic disorder characterized by spondyloepiphyseal dysplasia, renal dysfunction and immunodeficiency. Arteriosclerosis may also occur in some case. {ECO:0000269|PubMed:11799392, ECO:0000269|PubMed:18974355, ECO:0000269|PubMed:19793862}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Primary Focal Segmental Glomerulosclerosis FSGS;ATR signaling pathway (Consensus)

Recessive Scores

pRec
0.121

Intolerance Scores

loftool
0.0643
rvis_EVS
-0.13
rvis_percentile_EVS
44.09

Haploinsufficiency Scores

pHI
0.0676
hipred
N
hipred_score
0.306
ghis
0.548

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
N
essential_gene_gene_trap
K
gene_indispensability_pred
E
gene_indispensability_score
0.908

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Smarcal1
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; skeleton phenotype; renal/urinary system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; growth/size/body region phenotype;

Zebrafish Information Network

Gene name
smarcal1
Affected structure
nucleate erythrocyte
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
DNA strand renaturation;DNA metabolic process;DNA repair;regulation of transcription by RNA polymerase II;cellular response to DNA damage stimulus;replication fork processing;DNA rewinding;replication fork protection;t-circle formation
Cellular component
nucleus;nucleoplasm;DNA replication factor A complex;site of double-strand break;nuclear replication fork
Molecular function
helicase activity;protein binding;ATP binding;DNA-dependent ATPase activity;annealing helicase activity